期刊文献+

2型糖尿病糖耐量减低一级亲属经生活方式干预后不同转归者的特点分析 被引量:1

Characteristics of impaired glucose tolerance patients with different outcomes after one-year of lifestyle intervention in first degree relatives of type 2 diabetes
原文传递
导出
摘要 分析2型糖尿病糖耐量减低(IGT)一级亲属经1年生活方式干预后不同转归者的临床特点.160例IGT者中,56例(35.0%)转为正常糖耐量(NGT),44例(27.5%)发生2型糖尿病,60例(37.5%)仍为IGT.基线时3组BMI、胰岛素抵抗指数、空腹胰岛素无差异;但基线早时相胰岛素分泌在NGT组>IGT组>糖尿病组,基线糖化血红蛋白则相反.转为2型糖尿病组的基线胰岛素曲线下面积最高,基线肿瘤坏死因子-α最低.2型糖尿病的IGT一级亲属经1年生活方式干预后不同转归者存在明显差异. To evaluate the characteristics of impaired glucose tolerance(IGT) patients with different outcomes after one-year lifestyle intervention.A total of 160 IGT patients in first degree relatives of type 2diabetes mellitus(T2DM)completed the study.Among them,56 (35.0%) converted into normal glucose tolerance (NGT),44 (27.5%) progressed to T2DM and 60 (37.5%) stood still.Baseline BMI,homeostasis model assessment of insulin resistance(HOMA-IR) and fasting serum insulin were not different among three groups.However,basal Δ'I30/ΔG30 was greater in NGT group than IGT and T2DM groups.And hemoglobin A1c was greater in T2DM group than NGT and IGT groups.T2DM patients had a largest area of insulin under curve,but a lowest level of tumor necrosis factor-α.Therefore IGT patients with different outcomes after one-year intervention have different characteristics.
出处 《中华全科医师杂志》 2013年第10期826-829,共4页 Chinese Journal of General Practitioners
基金 国家重点基础研究发展计划(973计划)支持项目(2009CB523003) 天津市自然科学基金重点项目(13JCZDJC30500)
  • 相关文献

参考文献12

  • 1中华医学会糖尿病学分会.2010年版中国2型糖尿病防治指南.中华内分泌代谢杂志,2011,27:增录12b-1-增录12b-36.
  • 2Gupta-Ganguli M, Cox K, Means B, et al. Does therapy with anti-TNF-alpha improve glucose tolerance and control in patients with type 2 diabetes? . Diabetes Care, 2011, 34 :e121.
  • 3Tuomilehto J, Lindstrom J, Eriksson JG, et al. Diabetes Prevention Program Research Group. Prevention of type 2 diabetes mellitns by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med, 2001, 344:1343-1350.
  • 4Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metfonnin. N Engl J Med, 2002, 346:393-403.
  • 5Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention : a Japanese trial in IGT males. Diabetes Res Clin Pract, 2005, 67 : 152-162.
  • 6Saaristo T, Moilanen L, Korpi-Hyovalti E, et al. Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care, 2010, 33:2146- 2151.
  • 7DeFronzo RA, Abdul-Ghani M. Type 2 diabetes can be prevented with early pharmacological intervention. Diabetes Care, 2011, 34 Suppl 2 : S202-209.
  • 8严励,陈黎红,李静,唐菊英,黎锋,李焱,刘顺莲,戚以勤,程桦.2型糖尿病一级亲属胰岛素分泌功能的研究[J].中华内分泌代谢杂志,2008,24(1):10-12. 被引量:11
  • 9Knowler WC, Hamman RF, Edelstein SL, et al. Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes, 2005, 54 : 1150-1156.
  • 10Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care, 1997, 20: 537- 544.

二级参考文献8

共引文献11

同被引文献12

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部